Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Typhoid Vi Vaccination in Karachi Children
NCT00125047Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Oct 2001
- Primary completion
- Aug 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever (2 arms), sponsored by International Vaccine Institute. Primary endpoint: Total protection against S. typhi at 2 years. Started Oct 2001; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT00125047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125047.